Nature’s Sunshine Sets Second Quarter 2024 Conference Call for Thursday, August 8, 2024, at 5:00 p.m. ET
July 25, 2024 16:05 ET
|
Nature's Sunshine Products, Inc.
LEHI, Utah, July 25, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company offering high-quality herbal and...
Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update
July 25, 2024 16:05 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for...
Roivant to Report Financial Results for the First Quarter Ended June 30, 2024, and Provide Business Update on Thursday, August 8, 2024
July 25, 2024 16:05 ET
|
Roivant Sciences
BASEL, Switzerland and LONDON and NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday,...
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024 16:05 ET
|
TELA Bio, Inc.
MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
Fidus Investment Corporation Schedules Second Quarter 2024 Earnings Release and Conference Call
July 25, 2024 16:05 ET
|
Fidus Investment Corporation
EVANSTON, Ill., July 25, 2024 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”) today announced that it will report its second quarter 2024 financial results...
TILT Sets Second Quarter 2024 Conference Call for August 9 at 8:30 a.m. ET
July 25, 2024 16:05 ET
|
TILT Holdings Inc.
PHOENIX, July 25, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions that include inhalation...
Cytokinetics to Announce Second Quarter Results on August 8, 2024
July 25, 2024 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 8, 2024 at...
Ambitious Enterprise-Driven Agenda Takes Center Stage at MEF's Global NaaS Event
July 25, 2024 12:29 ET
|
MEF
The Enterprise-led, innovative conference program for MEF’s Global Network-as-a-Service Event (GNE), the only global NaaS event, is now live.
G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
July 25, 2024 11:15 ET
|
G1 Therapeutics
G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business
Update on August 8, 2024
ARKO to Report Second Quarter 2024 Financial Results on August 6, 2024
July 25, 2024 11:12 ET
|
ARKO CORP.
RICHMOND, Va., July 25, 2024 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (the “Company”) a Fortune 500 company and one of the largest convenience store operators in the United States, today...